PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7890663-8	1995	Gel filtration chromatography revealed that in contrast to r-apoA-I, the mutant apoA-I201 associated with a phospholipid-rich rabbit apoA-I containing particle.	Phospholipids	108-120	apolipoprotein A-I	Oryctolagus cuniculus	80-86	
2803350-8	1989	These data suggest that phospholipids improve the recognition of apo A-I by the A16 antibody.	Phospholipids	24-37	apolipoprotein A-I	Oryctolagus cuniculus	65-72	
21696737-0	2011	Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits.	Phospholipids	78-90	apolipoprotein A-I	Oryctolagus cuniculus	43-61	
21696737-1	2011	This study analyzed the antiatherogenic effects of newly developed apolipoprotein A-I (ApoA-I) mimetic peptide/phospholipid complexes (ETC-642) against the aortic plaque burden in vivo.	Phospholipids	111-123	apolipoprotein A-I	Oryctolagus cuniculus	87-93	
18342229-1	2008	OBJECTIVES: This study sought to evaluate in vivo the minimal dose of apolipoprotein (apo) A-I(Milano) phospholipid complex (recombinant apoA-I(Milano) and 1-palmitoyl-2-oleoyl phosphatidylcholine complexes [ETC-216]) able to induce atherosclerosis regression in a rabbit model of lipid-rich plaques.	Phospholipids	103-115	apolipoprotein A-I	Oryctolagus cuniculus	137-143	
18342231-0	2008	ApoA-I(Milano)/phospholipid complex: clinical implications of dose-response studies in rabbit atherosclerosis with intravascular ultrasound and magnetic resonance imaging.	Phospholipids	15-27	apolipoprotein A-I	Oryctolagus cuniculus	0-6	
16503760-6	2006	HDL formulations of recombinant apoA-I(Milano)-phospholipid complexes have clearly shown rapid regression of a focal carotid atheroma as well as powerful protection from myocardial infarction in a rabbit model.	Phospholipids	47-59	apolipoprotein A-I	Oryctolagus cuniculus	32-38